Hevolution CEO Dr. Mehmood Khan welcomed over 120 world-class speakers and nearly 2000 delegates to the inaugural Global Healthspan Summit to chart a new path for healthier aging and catalyze a worldwide shift from lifespan to healthspan. Hevolution to announce nearly $100 million during the two-day event to
Export House Status Holders are revered business leaders who have excelled in the realm of international trade Venus Remedies Limited, a noted name in the pharmaceutical industry, has received the prestigious "Three Star Export House" certificate from the Government of India. This certificate, given to
Obtaining market authorization for Bleomycin from MHRA is a momentous accomplishment for Venus Pharma GmbH. Venus Remedies holds a total of 15 Market Authorizations (MA) for Bleomycin products across the globe. Venus Remedies is thrilled to announce the achievement of market authorization in the United Kingdom
As the first pharmaceutical company in India to be honored with the REO certification from CII, Venus Remedies stands at the forefront of responsible and sustainable export practices. The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian
The $4.20-billion pharmaceutical market of the Philippines accounts for a significant market for Venus Remedies from the ASEAN region as the company moves a step closer towards emerging as the top oncology medicine supplier from India in Southeast Asia Venus Remedies’ oncology wing has
The Ecuador antibiotics market is majorly dependent on imports from India. Ecuador had imported antibiotics worth US $3.5 million in 2022. The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in
Mankind Pharma, a leading pharmaceutical company in India, is celebrating World Heart Day with a campaign to raise awareness on cardiac care and promote heart health. According to statistics published in ‘The Lancet’ in India, cardiovascular diseases affect 282 out of every 100,000 people, compared
In its steadfast commitment to enhancing quality healthcare access, Mankind Pharma, a leading pharmaceutical company is proud to unveil a significant stride with the introduction of 120 DMF (Drug Master File) Quality Medicines in the Indian market. Committed to delivering exceptional healthcare solutions at affordable
The company expects this marketing approval to enable it to rapidly expand its operations not only in Saudi Arabia, the largest pharma market in GCC region, but other GCC and MENA countries as well The marketing authorisation from Saudi Arabia comes as an evident
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025 Venus Remedies is targeting the $237-million antibiotic market in GCC region, out of which 35 per cent accounts for
